Bank Julius Baer & Co
INBX

Bank Julius Baer & Co’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bank Julius Baer & Co’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-140,566
Closed -$2.82M – 894
2021
Q1 		$2.82M Buy
+140,566
New +$4.1M 0.02% 238

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank Julius Baer & Co's INBX Position: Q2 2021 in Review

Bank Julius Baer & Co sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2021, closing a stake of 140,566 shares — an estimated $2.82M sold.

Bank Julius Baer & Co first reported a position in INBX in Q1 2021 and held it in 1 quarter. The position peaked at $2.82M in Q1 2021. 61 funds tracked by Wall St. Rank hold INBX as of Q2 2021.

  • Bank Julius Baer & Co reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 140,566 Inhibrx, Inc. Common Stock shares in Q2 2021, an estimated $2.82M.
  • Bank Julius Baer & Co first reported a position in Inhibrx, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Bank Julius Baer & Co's Inhibrx, Inc. Common Stock position peaked at $2.82M in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2021.

Based on Bank Julius Baer & Co's 13F filing for Q2 2021, filed 23 Jul 2021.